Virax Biolabs Group Statistics
NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
0.3319-0.0491 (-12.89%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Virax Biolabs Group by the numbers
Virax Biolabs Group has a market capitalization of $446,401 based on 1.34M shares outstanding. With trailing EPS of $-12.64, Virax Biolabs Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 78.8% below its 50-day average and 90.4% below its 200-day average.
Average daily trading volume is 360.62K shares, or about $119,689 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VRAX valuation vs. peer median
| Metric | VRAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $446.40K | $5.46M | -92% |
| Avg. volume | 360.62K | 100.65K | +258% |
Peer median across 8 companies: QCLS, CDIO, BMRA, TRIB, VNRX, IMDX, ICCC, NNNN.
Valuation
- Market cap
- $446.40K
- Price / sales (latest FY)
- 70.51
- EPS (TTM)
- $-12.64
- Shares outstanding
- 1.34M
Price and trading
- Previous close
- 0.381
- Open
- 0.3696
- Day range
- 0.3287 – 0.3696
- 52-week range
- 0.293 – 21.75
- Beta
- —
- Volume
- 85.67K
- Average volume
- 360.62K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 446.40K
- Forward Pe
- -0.06
- Eps
- -12.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.75
- Week52 Low
- 0.29
- Avg Volume
- 360.62K
- Shares Outstanding
- 1.34M
- Ma50
- 1.56
- Ma200
- 3.45
- Pct From52w High
- -98.47%
- Pct From52w Low
- 13.28%